Top

Current Treatment Options in Gastroenterology

Published in:

01-09-2017 | Endoscopy (P Siersema, Section Editor)

Endoscopic Surveillance in Long-standing Colitis

Authors: Brigid S. Boland, MD, Amandeep Shergill, MD, MS, Tonya Kaltenbach, MD, MAS

Published in: Current Treatment Options in Gastroenterology | Issue 3/2017

Opinion statement

There is a relative increase in the risk of colon cancer in patients with inflammatory bowel disease (IBD) affecting the colon, and endoscopic surveillance is advocated to mitigate this risk. The current standard practice is to survey this high-risk patient population using colonoscopy. Chromoendoscopy with targeted biopsies has emerged as the colonoscopy modality recommended by the major societies to optimize dysplasia detection. Studies over the past year support the improved yield from targeted as compared to random biopsies and improved dysplasia detection from chromoendoscopy as compared to white light endoscopy. Ongoing efforts should focus on the implementation of chromoendoscopy as the primary modality for colorectal cancer surveillance in IBD. Our review will describe current status and provide an update on the recent literature on surveillance colonoscopy in patients with IBD.

Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12):2724–9.CrossRefPubMed

Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–45.CrossRefPubMed

Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441–52.CrossRefPubMed

Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323(18):1228–33.CrossRefPubMed

Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19(4):789–99.CrossRefPubMed

Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):738–45.CrossRefPubMed

American Society for Gastrointestinal Endoscopy Standards of Practice C, Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101–21. e1101–1113

Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.CrossRefPubMed

Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103(5):1611–20.CrossRefPubMed

10.

Chiorean MV, Helper DJ, Saxena R, et al. Targeted biopsies using chromoendsocopy can replace random biopsies in pateints with IBD at high risk for colorectal neoplasia. Gastroenterol. 2012;142(supp1):S-339.CrossRef

11.

Gunther U, Kusch D, Heller F, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Color Dis. 2011;26(5):667–72.CrossRef

12.

Hlavaty T, Huorka M, Koller T, et al. Colorectal cancer screening in patients with ulcerative and Crohn’s colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol. 2011;23(8):680–9.CrossRefPubMed

13.

Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124(4):880–8.CrossRefPubMed

14.

• Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007;132(3):874–82. Randomized clinical trial of chromoendoscopy with endomicroscopy versus conventional colonoscopy, showing an increase in dysplasia detection with chromoendoscopy with endomicroscopy.CrossRefPubMed

15.

Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103(9):2342–9.CrossRefPubMed

16.

Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol. 2003;98(8):1827–33.CrossRefPubMed

17.

Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–60.CrossRefPubMedPubMedCentral

18.

Picco MF, Pasha S, Leighton JA, et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013;19(9):1913–20.PubMed

19.

Leong RW, Ooi M, Corte C, et al. Full-spectrum endoscopy improves surveillance for dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2017.

20.

• Carballal S, Maisterra S, Lopez-Serrano A, et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2016. Prospective clinical trial of segmental white light endoscopy followed by chromoendoscopy showing an increase yield in dysplasia with chromoendoscopy.

21.

Gasia MF, Ghosh S, Panaccione R, et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol. 2016;14(5):704–12. e704

22.

Rubin D, Cleveland NK, Rodriguez DM. Outcomes of colitis-associated dysplasia after referral from the community to a tertiary care center. Gastrointest Endosc. 2016;83(5S):AB439.CrossRef

23.

Marion JF, Waye JD, Israel Y, et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin Gastroenterol Hepatol. 2016;14(5):713–9.CrossRefPubMed

24.

Deepak P, Hanson GJ, Fletcher JG, et al. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016;83(5):1005–12.CrossRefPubMed

25.

• Choi CH, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110(10):1461–1471. quiz 1472. A retrospective study identified risk factors for progression to high grade dysplasia: lesions that were endoscopically invisible, lesions ≥1 cm, and prior biopsies that were indefinite for dysplasia.

26.

Iacucci M, Gasia MF, Olusey A, et al. Final results of a randomised study comparing high-definition colonoscopy alone wiht high-definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. ECCO Congress. 2016.

27.

Park SJ, Kim H.S.; Yang, D.; et al. High definition chromoendoscopy with water-jet versus high definition white light endoscopy in the detection of dysplasia in long standing ulcerative colitis: a multicenter prospective randomized controlled study. International Meeting on Intestinal Diseases in Conjunction with the Annual Congress of the Korean Association for the Study of Intestinal Diseases. 2016(FP2-1).

28.

Mohammed N, Kant P, Abid F, et al. High definition white light endoscopy (HDWLE) versus high definition with chromoendoscopy (HDCE) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc. 2015;81(5S):A446.

29.

Iannone A, Ruospo M, Wong G, et al. Chromoendoscopy for surveillance in ulcerative colitis and Crohn’s disease: a systematic review of randomized trials. Clin Gastroenterol Hepatol 2016.

30.

Dekker E, van den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy. 2007;39(3):216–21.CrossRefPubMed

31.

Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol. 2012;107(6):885–90.CrossRefPubMed

32.

van den Broek FJ, Fockens P, van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy. 2011;43(2):108–15.CrossRefPubMed

33.

Ten Hove JR, Mooiweer E, van der Meulen de Jong AE, et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy 2016.

34.

Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25(6):657–68.CrossRefPubMed

35.

• Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60(3):334–9. Prospective cohort study showing that most colonic lesions can be identified with chromoendoscopy.CrossRefPubMed

36.

• Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81(3):489–501 e426. SCENIC international consensus statement guiding surveillance and management of dysplasia in the setting of inflammatory bowel disease.CrossRefPubMed

37.

Rutter MD. Surveillance programmes for neoplasia in colitis. J Gastroenterol. 2011;46(Suppl 1):1–5.CrossRefPubMed

38.

Bopanna S, Kedia S, Ahuja V. A low-cost method for chromoendoscopy for surveillance in ulcerative colitis. Indian J Gastroenterol. 2016;35(6):482–5.CrossRefPubMed

39.

• Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151(6):1122–30. Randomized controlled study of surveillance in ulcerative colitis showing that the neoplasia yield from targeted biopsies is greater than random biopsies.CrossRefPubMed

40.

Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2017.

41.

Sanduleanu S, Kaltenbach T, Barkun A, et al. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83(1):213–22.CrossRefPubMed

42.

Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014;79(3):455–65.CrossRefPubMed

Title: Endoscopic Surveillance in Long-standing Colitis
Authors: Brigid S. Boland, MD
Amandeep Shergill, MD, MS
Tonya Kaltenbach, MD, MAS
Publication date: 01-09-2017
Publisher: Springer US
Published in: Current Treatment Options in Gastroenterology / Issue 3/2017
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI: https://doi.org/10.1007/s11938-017-0141-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Endoscopic Surveillance in Long-standing Colitis

Opinion statement

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Opinion statement

Please log in to get access to this content

Other articles of this Issue 3/2017

Dysphagia in the Elderly

Endoscopic Stents for the Biliary Tree and Pancreas

Intractable Constipation in the Elderly

The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly

Endoscopic Palliation of Pancreatic Cancer

Quality Indicators in Colonoscopy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page